A quantitative approach to benefit-risk assessment of medicines - Part 1: The development of a new model using multi-criteria decision analysis; part 2: The practical application of a new model

Pharmacoepidemiology and Drug Safety

Volumn 16, Issue SUPPL. 1, 2007, Pages

  Mussen, Filip ^a   Salek, Sam ^a   Walker, Stuart ^a   Abadie, E ^a   Alvan, Gunnar ^b   Breckenridge, Alasdair ^a   Flamion, Bruno ^c   Jefferys, David ^d  

^a Evaluation Thérapeutique et de la Gestionh des Procédures d' AMM ^*

^b MEDICAL PRODUCTS AGENCY   (Sweden)

^c Faculty of Medicine   (Belgium)

^d EISAI CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT;

CONTENT VALIDITY; DRUG APPROVAL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; HUMAN; MATHEMATICAL MODEL; MEDICAL DECISION MAKING; MULTICRITERIA DECISION ANALYSIS; NOTE; PRIORITY JOURNAL; PSYCHOSIS; QT PROLONGATION; QUANTITATIVE ANALYSIS; RISK BENEFIT ANALYSIS;

DECISION SUPPORT TECHNIQUES; DRUGS, INVESTIGATIONAL; HUMANS; INTERDISCIPLINARY COMMUNICATION; MODELS, BIOLOGICAL; PHARMACOEPIDEMIOLOGY; RISK ASSESSMENT;

EID: 34547546947     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1436     Document Type: Note

References (0)